BLOOD LEVELS OF FATTY ALDEHYDES IN CORONARY HEART DISEASE AND ATHEROSCLEROSIS
Abstract
Aim. To investigate the levels of fatty aldehydes and oxidised fatty acid radicals in erythrocytes and plasma lipids among patients with atherosclerosis and coronary heart disease (CHD). Material and methods. The study included patients with diagnosed CHD and coronary artery atherosclerosis, as well as healthy volunteers (controls). The levels of fatty aldehydes and oxidised fatty acid radicals were assessed using the capillary gas-liquid chromatography method. Results. CHD patients demonstrated elevated erythrocyte levels of fatty aldehydes and oxidised fatty radicals, as well as an increased relative content of fatty aldehydes in plasma lipids. Conclusion. Blood acidosis could play an important role in the elevation of fatty aldehyde levels in erythrocytes among patients with atherosclerosis and myocardial ischemia.
About the Authors
A. N. Osipenko
УО «Могилевский государственный университет им. А. А. Кулешова»,
Могилев, Беларусь
Belarus
A. A. Kuleshov Mogilev State University. Mogilev, Belarus
Belarus
A. A. Kuleshov Mogilev State University. Mogilev, Belarus
N. V. Akulich
УО «Могилевский государственный университет им. А. А. Кулешова»,
Могилев, Беларусь
Belarus
A. A. Kuleshov Mogilev State University. Mogilev, Belarus
Belarus
A. A. Kuleshov Mogilev State University. Mogilev, Belarus
References
1. Kurashvili, L.V. Vasil’kov V.G. Lipid metabolism on emergency conditions. Penza; 2003. Russian (Курашвили Л.В., Васильков В.Г. Липидный обмен при неотложных состояниях. Пенза; 2003).
2. Titov V.N., Lisicyn D.M. Fatty acids. Physical chemistry, biology and medicine. M.: – Tver’: Triada; 2006. Russian (Титов В.Н., Лисицын Д.М. Жирные кислоты. Физическая химия, биология и медицина. М.: – Тверь: Триада; 2006).
3. Zajchik A.Sh., Churilov L.P. Common pathophysiology (with the fundamentals of immunopathology). SPb.: JeLBI-SPb; 2005. Russian (Зайчик А.Ш., Чурилов Л.П. Общая патофизиология (с основами иммунопатологии). СПб.: ЭЛБИ-СПб; 2005).
4. Klimov A.N., Nikul’cheva N.G. Lipids, lipoproteins and atherosclerosis. SPb.: Piter Press; 1995. Russian (Климов А.Н., Никульчева Н.Г. Липиды, липопротеиды и атеросклероз. СПб.: Питер Пресс; 1995).
5. Boldyrev A.A., Kjajvjarjajnen E.I., Iljuha V.A. Biomembranology. Petrozavodsk: Izdvo Kar NC RAN; 2006. Russian (Болдырев А.А., Кяйвяряйнен Е.И., Илюха В.А. Биомембранология. Петрозаводск: Изд-во Кар НЦ РАН; 2006).
6. Khan M., Singh J., Singh I. Plasmalogen deficiency in cerebral adrenoleukodystrophy and its modulation by lovastatin. Neurochem 2008; 106 (4): 1766–1779.
7. Kejts M. Technique of lipidology. Introduction, analysis and identification of lipids. M.: Mir; 1975. Russian (Кейтс М. Техника липидологии. Выделение, анализ и идентификация липидов. М.: Мир; 1975).
8. Medik V.A., Tokmachev M.S., Fishman B.B. Statistics in medicine and biology: manual in two volumes. M.: Medicina, 2000: 1. Theoretical statistics. Russian (Медик В.А., Токмачев М.С., Фишман Б.Б. Статистика в медицине и биологии: руководство в 2 т. М.: Медицина; 2000; 1. Теоретическая статистика).
9. Farooqui A.A., Rapoport S.I., Horrocks L.A. Membrane phospholipid alterations in Alzheimer’s disease: deficiency of ethanolamine plasmalogens. J. Neurochem. Res. 1997; 22 (4): 523–527.
10. Kovacs W.J., Shackelford J.E., Tape K.N. et al. Disturbed cholesterol homeostasis in a peroxisome-deficient PEX2 knockout mouse model. J. Mol. Cell. Biol. 2004; 24 (1): 1–13.
11. Farooqui A.A., Yang H.C., Horrocks L.A. Plasmalogens, phospholipases A2 and signal transduction. Brain Res. Rev. 1995; 21 (2):152–161.
12. Osipenko A.N., Akulich N.V., Marochkov A.V. and other. Imbalance of fatty acids at angiopathic states of various genesis. Molodezh’ v nauke – 2009: pril. k zhurn. «Vesci Nacyjanal’naj akadjemii navuk Belarusi» 2010; V 5 ch. Ch. 4: 414-419. Russian (Осипенко А.Н., Акулич Н.В., Марочков А.В. и др. Нарушение баланса жирных кислот при ангиопатических состояниях различного генеза. Молодежь в науке 2009: прил. к журн. «Весцi Нацыянальнай акадэмii навук Беларусi» 2010; В 5 ч. Ч. 4: 414-419).
13. Mandel H., Getsis M., Rosenblat M. et al. Reduced cellular cholesterol content in peroxisomedeficient fibroblasts is associated with impaired uptake of the patient’s low density lipoprotein and with reduced cholesterol synthesis. J. Lipid Res. 1995; 36 (6): 1385–1391.
Review
For citations:
Osipenko A.N., Akulich N.V. BLOOD LEVELS OF FATTY ALDEHYDES IN CORONARY HEART DISEASE AND ATHEROSCLEROSIS. Russian Journal of Cardiology. 2012;(2):34-37. (In Russ.)
Views:
643
Email this article 